Sam Chun Dang Pharm. Co., Ltd

Informe acción KOSDAQ:A000250

Capitalización de mercado: ₩2.6t

Sam Chun Dang Pharm Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Dae-In Yoon

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO7.1%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking

Mar 21
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking

Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly

Feb 26
Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly

Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%

Feb 09
Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%

Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?

Jan 05
Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?

Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly

Dec 01
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly

CEO

Dae-In Yoon (73 yo)

no data

Permanencia

Dae-In Yoon serves as the Chief Executive Officer and Chairman of Sam Chun Dang Pharmacy. Dae-In Yoon serves as Chief Executive Officer and Chairperson of Sam Chun Dang Pharm Co. Ltd. Dae-In Yoon serves as...